1-5 of 5
Seint T. Lwin
Close
Sort by
Journal Articles

Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease

Jessica A. Fowler, Seint T. Lwin, Matthew T. Drake, James R. Edwards, Robert A. Kyle, Gregory R. Mundy, Claire M. Edwards
Journal: Blood
Blood (2011) 118 (22): 5872–5882.
https://doi.org/10.1182/blood-2011-01-330407
Published: 2011
Includes: Supplemental data
Journal Articles

Osteoclasts in Myeloma Are Derived from Gr-1 + CD11b + Myeloid Immune Suppressor Cells of the Bone Marrow Niche in Vivo

Junling Zhuang, M.D., Ph.D., Li Yang, Ph.D., Seint T Lwin, B.S., Claire M. Edwards, PhD, BSc, James R Edwards, Ph.D., Gregory R Mundy, M.D.
Journal: Blood
Blood (2008) 112 (11): 736.
https://doi.org/10.1182/blood.V112.11.736.736
Published: 2008
Journal Articles

Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo

Claire M. Edwards, James R. Edwards, Seint T. Lwin, Javier Esparza, Babatunde O. Oyajobi, Brandon McCluskey, Steven Munoz, Barry Grubbs, Gregory R. Mundy
Journal: Blood
Blood (2008) 111 (5): 2833–2842.
https://doi.org/10.1182/blood-2007-03-077685
Published: 2008
Journal Articles

Protein Profiling in Myeloma In Vivo ; Effects of Bortezomib in a Mouse Model of Myeloma.

Claire M. Edwards, PhD, Robert L. Caldwell, PhD, Andreia L. Bates, Jessica A. Fowler, James R. Edwards, PhD, Babatunde O. Oyajobi, MD, PhD, Seint T. Lwin, Jianghong Zhang, PhD, Gregory R. Mundy, MD
Journal: Blood
Blood (2007) 110 (11): 255.
https://doi.org/10.1182/blood.V110.11.255.255
Published: 2007
Journal Articles

Targeting Wnt Signaling in Myeloma In Vivo ; Differential Effects on Tumor Burden and Myeloma Bone Disease.

Claire M. Edwards, PhD, James R. Edwards, PhD, Seint T. Lwin, Gregory R. Mundy, MD
Journal: Blood
Blood (2007) 110 (11): 812.
https://doi.org/10.1182/blood.V110.11.812.812
Published: 2007